论文部分内容阅读
目的探究卡孕栓预防产后出血的疗效,为临床提供指导。方法抽取来本院就医的60例子宫出血患者(2015年2月至2016年2月)作为此次实验的目标对象,对60例子宫出血患者进行随机对照分组。对照组30例患者应用缩宫素治疗,实验组30例患者应用卡孕栓治疗,研究对比两组子宫出血患者的产后2h出血量、第三产程时间及不良反应发生率。结果实验组子宫出血患者的产后2h出血量及第三产程时间显著优于对照组,P<0.05;但对照组患者的不良反应发生率为10.00%,和实验组无显著区别,P>0.05。结论卡孕栓预防产后出血具有较显著的临床疗效,可有效缩短第三产程时间,减少产后2h出血量。
Objective To investigate the effect of carbamazepine in preventing postpartum hemorrhage and provide guidance for clinical practice. Methods Sixty patients with uterine bleeding who were admitted to our hospital from February 2015 to February 2016 were selected as the target group and 60 patients with uterine bleeding were randomly divided into two groups. Thirty patients in the control group were treated with oxytocin. 30 patients in the experimental group were treated with carboplatin. The amount of bleeding, the third stage of labor and the incidence of adverse reactions were compared between the two groups. Results The amount of bleeding and the third stage of labor in patients with uterine bleeding in experimental group were significantly better than those in control group (P <0.05). However, the incidence of adverse reactions in control group was 10.00%. There was no significant difference between experimental group and control group (P> 0.05). Conclusions Carprost suppository has a significant clinical effect in preventing postpartum hemorrhage, which can effectively shorten the time of the third stage of labor and reduce the amount of hemorrhage after 2 hours of delivery.